Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04463485
Other study ID # Delayed Cord Clamping RCT
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 21, 2017
Est. completion date December 30, 2018

Study information

Verified date July 2020
Source Mersin University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research was conducted to carry out the effect of umbilical cord clamping time on baby anemia.


Description:

This study is an experimental, randomized controlled study. The sample of the study consisted of 65 pregnant women and newborns (intervention=32, control=33) who applied for delivery at Ege University Medical Hospital Gynecology and Obstetrics Clinic at the time of the study. In this study, "Descriptive Data Form of Impact of Umbilical Cord Clamping Time on Infant Anemia" was used as a data collection tool. In the intervention group waited 60 seconds for umbilical cord clamping in the second stage of labor, in the control group the umbilical cord was clamped in the first 15 seconds. For the data of the first stage of the study, the neonatal hematocrit and bilirubin measurements and the need for phototherapy due to hyperbilirubinemia were evaluated 48 hours after birth. In the second stage of the study, data on anaemia screening performed in family medicine at the end of the fourth month of birth were examined. Statistical analysis of the data from the study was performed using IBM SPSS Statistics 25.0 package program. Parametric tests were used for statistical analysis of the data with a normal distribution. The level of statistical significance was determined as p<0.05.


Recruitment information / eligibility

Status Completed
Enrollment 65
Est. completion date December 30, 2018
Est. primary completion date August 30, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years to 35 Years
Eligibility Inclusion Criteria:

- Apply for normal birth

- Singleton pregnancy and live fetus

- Cephalic presentation

- Estimated birth weight between 2500-4000 grams

- Birth rates <5

- Women who received iron support during pregnancy

- Haemoglobin level = 11 gr/dL

- No systemic disease or pregnancy complication that may pose a risk for postpartum bleeding.

- Neonates who don't need for resuscitation after birth

- Babies who did not receive iron supplements up to the 4th month after birth were included.

Exclusion Criteria:

- Pregnant women who refuse to participate in the research

- Neonates who need for resuscitation after birth

- Babies who receive iron supplements up to the 4th month after birth were excluded.

Study Design


Intervention

Procedure:
Delayed Clamping
Umbilical cord clamping was delayed 60 seconds at the end of second stage of labor.

Locations

Country Name City State
Turkey Ege University Medical Hospital Obstetric and Gynecology Department Izmir

Sponsors (1)

Lead Sponsor Collaborator
Mersin University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Neonatal Haematocrit Value at 48th Hours of Life Haematocrit measurement in capillary blood taken from newborn after birth 48th hours after birth
Primary Neonatal Bilirubin Value at 48th Hours of Life Bilirubin measurement in capillary blood taken from newborn after birth 48th hours after birth
Primary Phototherapy Requirement Rates due to Hyperbilirubinemia Neonatal phototherapy requirement due to hyperbilirubinemia in the postpartum period 3 or 14 days of age
Primary Haemoglobin Values of 4 Month Infants Haemoglobin measurement at baby's 4th month of age Infants' 4th month of age
Primary Haematocrit Values of 4 Month Infants Haematocrit measurement at baby's 4th month of age Infants' 4th month of age
Primary Diagnosis of Anemia Rates of 4 Month Infants Screening of the family medicine center, condition of the baby diagnosed with anemia at 4th month of age Infants' 4th month of age
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1